U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316712) titled 'Effect of TECAR (Transfer of Energy Capacitive and Resistive) Therapy on Chronic Supraspinatus Tendinitis' on Dec. 19, 2025.
Brief Summary: This study aims to investigate the effect of TECAR therapy on pain, shoulder range of motion, functional disability, and handgrip strength in patients with grade II supraspinatus tendinitis.
Study Start Date: Dec. 30, 2025
Study Type: INTERVENTIONAL
Condition:
Supraspinatus Tendinitis
Intervention:
OTHER: Conventional treatment
All patients in both groups will receive conventional treatment, 3 sessions per week for 3 weeks. The conventional methods for treating supraspinatus tendinitis inc...